Cohen Yuval
Chief Executive Officer
Cohen Yuval has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Cohen Yuval is listed as Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Cohen Yuval reported no open-market purchases and 4 open-market sales totaling $751K in CRBP. The largest disclosed transaction in the window is a sale of 18,660 CRBP shares on Oct 24, 2025, worth $317K.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$751K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cohen Yuval made?
Cohen Yuval has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Cohen Yuval trade?
Cohen Yuval has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Cohen Yuval's most recent SEC Form 4 filing?
Cohen Yuval's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Cohen Yuval's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cohen Yuval is listed as Chief Executive Officer.
What is Cohen Yuval's total buy and sell value in the current window?
Inside the rolling retention window, Cohen Yuval bought $0 and sold $751K based on SEC Form 4 filings.
What was Cohen Yuval's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,660 CRBP shares on 2025-10-24, worth $317K, per SEC Form 4 filings.